Updates and Resources

Information about Additional Doses of COVID-19 Vaccine

At this time, federal health officials recommend additional doses of the certain COVID-19 vaccines for specific groups of people. Public health officials ask that you only seek a third dose or a booster if you qualify for one at this time. The FDA and CDC are expected to issue additional recommendations in the coming weeks.

Booster Shots of the Pfizer COVID-19 Vaccine

The Centers for Disease Control recommends booster shots of the Pfizer vaccine only for the following groups:

• people 65 years and older and residents in long-term care settings should receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series,
• people aged 50-64 years with underlying medical conditions should receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series,
• people aged 18-49 years with underlying medical conditions may receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series, based on their individual benefits and risks, and
• people aged 18-64 years who are at increased risk for COVID-19 exposure and transmission because of occupational or institutional setting may receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series, based on their individual benefits and risks.

Third Doses for People who are Moderately to Severely Immunocompromised

Third doses of the Pfizer and Moderna vaccines are recommended for people who are moderately to severely immunocompromised. These individuals need an additional dose because data now show that they do not build up enough protection against COVID-19 infection when they get their first two doses.

Public health officials ask that you only seek a third dose or a booster if you qualify for one at this time. The FDA and CDC are expected to issue additional recommendations in the coming weeks.